{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:39:03Z","timestamp":1770331143476,"version":"3.49.0"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>In the absence of significant benefit from either novel therapeutics or screening, the focus of decreasing ovarian cancer incidence and mortality has shifted toward primary prevention. Histopathologic data have demonstrated that up to 70% of ovarian cancers may actually arise from the fallopian tube. This has led to the increased adoption of opportunistic salpingectomy as a tool for ovarian cancer prevention. In turn, the potential surgical risks and ovarian cancer prevention of this emerging practice have generated multiple studies. In this comprehensive review, we address the origins of ovarian cancer, the historical context and recent trends of tubal surgery, the existing population-based data on ovarian cancer risk reduction, and provide a detailed review of the evidence on surgical risks of salpingectomy. To date, the safety and ovarian cancer risk reduction evidence sheds a positive light on opportunistic salpingectomy. Although research on this subject has grown substantially in recent years, there remains a paucity of large, prospective studies that examine clinical outcomes.<\/jats:p>","DOI":"10.1097\/aog.0000000000002243","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T22:20:15Z","timestamp":1504822815000},"page":"814-824","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":44,"title":["The Evolution of and Evidence for Opportunistic Salpingectomy"],"prefix":"10.1097","volume":"130","author":[{"given":"Sarah E.","family":"Dilley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Straughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Leath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-20241011","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","article-title":"An international assessment of ovarian cancer incidence and mortality","volume":"130","author":"Lowe","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R4-20241011","first-page":"270","article-title":"Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up","volume":"143","author":"Pinsky","year":"2016","journal-title":"Cancer"},{"key":"R5-20241011","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"R6-20241011","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.29321","article-title":"Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer","volume":"121","author":"Walker","year":"2015","journal-title":"Cancer"},{"key":"R7-20241011","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ajog.2015.03.044","article-title":"New insights in the pathophysiology of ovarian cancer and implications for screening and prevention","volume":"213","author":"Nezhat","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20241011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"R9-20241011","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"R10-20241011","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"R11-20241011","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin? [Published erratum appears in Am J Surg Pathol 2010;34:1891]","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R12-20241011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R13-20241011","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R14-20241011","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","article-title":"A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development","volume":"233","author":"Sherman-Baust","year":"2014","journal-title":"J Pathol"},{"key":"R15-20241011","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R16-20241011","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"R17-20241011","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00404-013-3041-3","article-title":"Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube","volume":"289","author":"Dietl","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"R18-20241011","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/AOG.0b013e318299a6cf","article-title":"Nationwide trends in the performance of inpatient hysterectomy in the United States","volume":"122","author":"Wright","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R19-20241011","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/jamasurg.2016.0804","article-title":"Trends in inpatient and outpatient hysterectomy and oophorectomy rates among commercially insured women in the United States, 2000\u20132014","volume":"151","author":"Doll","year":"2016","journal-title":"JAMA Surg"},{"key":"R20-20241011","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/AOG.0000000000002103","article-title":"Outpatient hysterectomy volume in the United States","volume":"130","author":"Cohen","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R21-20241011","doi-asserted-by":"crossref","first-page":"713.e1","DOI":"10.1016\/j.ajog.2015.04.031","article-title":"National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998\u20132011","volume":"213","author":"Mikhail","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20241011","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian Conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R23-20241011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2010.03.029","article-title":"Tubal sterilization trends in the United States","volume":"94","author":"Chan","year":"2010","journal-title":"Fertil Steril"},{"key":"R24-20241011","first-page":"23","article-title":"Sterilization in the United States","volume":"1","author":"Bartz","year":"2008","journal-title":"Rev Obstet Gynecol"},{"key":"R27-20241011","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.AOG.0000459871.88564.09","article-title":"Salpingectomy for ovarian cancer prevention. Committee Opinion No. 620. American College of Obstetricians and Gynecologists","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R28-20241011","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/AOG.0000000000000422","article-title":"Female tubal sterilization: the time has come to routinely consider removal","volume":"124","author":"Creinin","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R29-20241011","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ygyno.2013.04.021","article-title":"Opportunistic salpingectomy for women at low risk for development of ovarian carcinoma: the time has come","volume":"129","author":"Gilks","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R30-20241011","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20241011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3747\/co.20.1560","article-title":"Examining the use of salpingectomy with hysterectomy in Canada","volume":"20","author":"Sandoval","year":"2013","journal-title":"Curr Oncol"},{"key":"R32-20241011","doi-asserted-by":"crossref","first-page":"270.e1","DOI":"10.1016\/j.ajog.2016.10.035","article-title":"The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States","volume":"216","author":"Hanley","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20241011","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/AOG.0000000000001531","article-title":"Experience with opportunistic salpingectomy in a large, community-based health system in the United States","volume":"128","author":"Garcia","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R34-20241011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R35-20241011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis","volume":"5","author":"Rice","year":"2012","journal-title":"J Ovarian Res"},{"key":"R36-20241011","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum Reprod"},{"key":"R37-20241011","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R38-20241011","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3747\/co.20.1492","article-title":"Opportunistic salpingectomy: the way forward\u2014response to Steven Narod","volume":"20","author":"Miller","year":"2013","journal-title":"Curr Oncol"},{"key":"R39-20241011","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3747\/co.20.1471","article-title":"Salpingectomy to prevent ovarian cancer: a countercurrents series","volume":"20","author":"Narod","year":"2013","journal-title":"Curr Oncol"},{"key":"R40-20241011","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","article-title":"Effect of tubal sterilization technique on risk of serous ovarian and primary peritoneal carcinoma","volume":"135","author":"Lessard-Anderson","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R41-20241011","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case\u2013control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R42-20241011","doi-asserted-by":"crossref","first-page":"dju410","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R43-20241011","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","article-title":"Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis","volume":"55","author":"Yoon","year":"2016","journal-title":"Eur J Cancer"},{"key":"R44-20241011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3747\/co.20.1548","article-title":"Fallopian tube removal: \u201cstic-ing\u201d it to ovarian cancer: what is the utility of prophylactic tubal removal?","volume":"20","author":"Herzog","year":"2013","journal-title":"Curr Oncol"},{"key":"R45-20241011","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.13741","article-title":"Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: there is lack of clarity on a number of key issues","volume":"123","author":"Manchanda","year":"2016","journal-title":"BJOG"},{"key":"R46-20241011","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.fertnstert.2013.09.039","article-title":"Prophylactic salpingectomy in premenopausal women at low risk for ovarian cancer: risk-reducing or risky?","volume":"100","author":"Tanner","year":"2013","journal-title":"Fertil Steril"},{"key":"R47-20241011","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere","volume":"129","author":"Morelli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R48-20241011","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00432-014-1622-6","article-title":"Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate","volume":"140","author":"Vorwergk","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"R49-20241011","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jmig.2015.02.013","article-title":"Surgical outcomes and complications of prophylactic salpingectomy at the time of benign hysterectomy in premenopausal women","volume":"22","author":"Minig","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R50-20241011","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/humrep\/der116","article-title":"FINHYST, a prospective study of 5279 hysterectomies: complications and their risk factors","volume":"26","author":"Brummer","year":"2011","journal-title":"Hum Reprod"},{"key":"R51-20241011","doi-asserted-by":"crossref","first-page":"53.e1","DOI":"10.1016\/j.ajog.2014.07.027","article-title":"A retrospective analysis of the effect of salpingectomy on serum antiM\u00fcllerian hormone level and ovarian reserve","volume":"212","author":"Ye","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R52-20241011","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/aogs.12234","article-title":"Anti-M\u00fcllerian hormone levels in salpingectomized compared with nonsalpingectomized women with tubal factor infertility and women with unexplained infertility","volume":"92","author":"Grynnerup","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R53-20241011","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jmig.2016.08.833","article-title":"3 to 5 years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function","volume":"24","author":"Venturella","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"R54-20241011","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.fertnstert.2013.07.1997","article-title":"Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial","volume":"100","author":"Findley","year":"2013","journal-title":"Fertil Steril"},{"key":"R55-20241011","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/djn103","article-title":"Cost of care for elderly cancer patients in the United States","volume":"100","author":"Yabroff","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R56-20241011","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","article-title":"Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy","volume":"125","author":"Kwon","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"R57-20241011","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ygyno.2017.05.034","article-title":"Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention","volume":"146","author":"Dilley","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R58-20241011","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0002-9378(96)70658-0","article-title":"The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization","volume":"174","author":"Peterson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R59-20241011","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2004.07.970","article-title":"Spontaneous pregnancy after bilateral salpingectomy","volume":"83","author":"Bollapragada","year":"2005","journal-title":"Fertil Steril"},{"key":"R60-20241011","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejogrb.2011.06.014","article-title":"Intra-uterine spontaneous viable twin pregnancy after bilateral salpingectomy","volume":"159","author":"Kahyaoglu","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R61-20241011","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9378(85)80148-4","article-title":"Sterilization failures and their causes","volume":"152","author":"Soderstrom","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"R62-20241011","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jmig.2016.05.006","article-title":"Postpartum permanent sterilization: could bilateral salpingectomy Replace bilateral tubal ligation?","volume":"23","author":"Danis","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"R64-20241011","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jmig.2015.05.010","article-title":"Round ligament technique and use of a vessel-sealing device to facilitate complete salpingectomy at the time of vaginal hysterectomy","volume":"22","author":"Kho","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R65-20241011","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jmig.2015.04.012","article-title":"Success and complications of salpingectomy at the time of vaginal hysterectomy","volume":"22","author":"Robert","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R67-20241011","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R68-20241011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201710000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T15:01:32Z","timestamp":1728658892000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201710000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002243","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}